Simon Fraser University (SFU) has recently garnered substantial recognition and support in the realm of academic and entrepreneurial innovation, particularly…
Boehringer Ingelheim’s investigational schizophrenia candidate has failed to improve cognitive impairment or functioning in a trio of late-stage trials. The…